Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Araris Biotech
Araris Biotech
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Araris Biotech
Total Funding
$43.4 M
Araris Biotech Summary
Company Summary
Overview
Araris Biotech is a company that develops ADC-based safe and potent drugs for various diseases and ailments. Its linker platform enables the attachment of any payload to "off-the-shelf" antibodies without the need for prior antibody engineering.
Type
Private
Status
Active
Founded
2019
HQ
Zürich, CH
|
view all locations
Website
https://www.ararisbiotech.com/
Cybersecurity rating
Sectors
Manufacturing & Industrial
biotech
drug development
pharma
Homepage
Table of Contents
Key People
Locations
Competitors
Key People
Philipp Spycher,
Co-Founder and CEO
Isabella Attinger,
Co-Founder and VP Translational Research
Dragan Grabulovski,
Co-Founder and Chairman (Board)
Locations
View all
1 location detected
Zürich, ZH
HQ
Switzerland
HPL, Otto-Stern-Weg 7
Competitors and Similar Companies
ADC Therapeutics
Healthcare - Public
Mersana Therapeutics
Healthcare - Public
NBE-Therapeutics
Healthcare - Private
Qilu Pharmaceutical
Manufacturing & Industrial - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top